Main container

Pazzaglia Laura, MSc, PhD

CV

Date of Birth
07/02/1974
Qualification

MSc, PhD Biologist (permanent staff)

Current assignment

Study of gene expression in musculoskeletal tumors

Title of qualification awarded

2000: Degree in Biological Science at the University of Bologna 

Other qualifications awarded

2006: PhD in Oncology at the University of Bologna

Positions held
  • 2001-2003: Biologist fellow at the Laboratory of Cancer Research of the Rizzoli Ortopaedic Institute (Bologna)
  • 2003-2006: Biologist fellow of University of Bologna at the Laboratory of Cancer Research of the Rizzoli Ortopaedic Institute (Bologna)
  • 2006- July 2009: Biologist contractor researcher at the Laboratory of Cancer Research of the Rizzoli Ortopaedic Institute (Bologna)
  • From July 2009 until today: Biologist (permanent staff) at the Laboratory of Experimental Oncology of the Rizzoli Ortopaedic Institute (Bologna) in the U.O Molecular Characterization of Sarcoma.
Languages

Italian: mother tongue
English: scholastic
French: scholastic

Technologies
  • main techniques of molecular and cellular biology
  • Windows Office; Molecular Biology software/database.
Teaching activities

Tutoring activities for undergraduates.

Scientific activities

Since 2005  collaborator of  Research Projects funded by the  Emilia-Romagna Region, the Ministry of Health (Current and Finalized Research) and the European Union.

Research activity abroad: 23/08/2010 - 04/09/2010 Laboratory of Cytomolecular Genetics Research - University of Helsinki. Project: miRNA analysis in musculoskeletal sarcoma by microarray.

  • From 2012 member of the Italian Sarcoma Group (ISG);
  • From 2013 member of the Italian Cancer Society (SIC);
  • From 2013 member of the European Association for Cancer Research (EACR).

Author or co-author of publications on international journals.

Reference:

  • ORCID: 0000-0001-5937-4953;
  • SCOPUS: 6602544011;
  • Research ID: C-7918-2019.
Clinical and/or Scientific interests

Mainly occupied in characterization at the molecular level of sarcomas of the musculoskeletal system, in order to identify prognostic and diagnostic markers.